1/10/2020 | CV | Market Commentary: MongoDB, Luckin convertibles hit aftermarket, expand on debut; Dermira skyrockets
|
12/11/2019 | CV | Market Commentary: Impinj convertible offering eyed; Everbridge convertible notes hit market; Lumentum up
|
4/8/2019 | CV | Market Commentary: Convertibles trading light; Dermira notes improve; Fortive active in secondary market
|
4/8/2019 | CV | Market Commentary: Morning Commentary: Convertibles trading light; Dermira improves; Encore Capital active
|
3/19/2019 | CV | Market Commentary: Euronet Worldwide convertibles in focus; DexCom notes active; Dermira gains continue
|
3/18/2019 | CV | Market Commentary: Dermira convertibles jump; Euronet Worldwide improves again; NII Holdings gains ground
|
3/18/2019 | CV | Market Commentary: Morning Commentary: Dermira convertibles jump in active trading; Citrix Systems active
|
1/23/2019 | CV | Market Commentary: Morning Commentary: Citrix Systems in focus pre-earnings; Workday, Dermira notes active
|
12/4/2018 | HYIG | Market Commentary: Dermira inks $125 million five-year loan; Unitil places $30 million
|
12/4/2018 | PV | New Issue: Dermira negotiates $125 million five-year 10.75% loan with Athyrium
|
10/19/2018 | CV | Market Commentary: Convertibles activity muted; Cleveland-Cliffs contracts post-earnings; Citrix active
|
6/29/2018 | CV | Market Commentary: Convertibles wrap active week; Zillow, Intrexon, Arbor Realty price; Dermira in focus
|
3/6/2018 | CV | Market Commentary: Assurant convertible preferreds on tap; Western Digital, Nutanix reach new heights
|
3/5/2018 | CV | Market Commentary: Dermira convertible tanks on clinical trial failures; Micron eyed as stock breaks out
|
7/20/2017 | CV | Market Commentary: Dermira active, steady; HubSpot trends up; Ensco drifts lower; Crown Castle deal eyed
|
7/20/2017 | CV | Market Commentary: Morning Commentary: Dermira convertibles active, steady; Crown Castle new issue on deck
|
5/16/2017 | CV | Dermira greenshoe exercised, lifts 3% convertibles to $287.5 million
|
5/12/2017 | CV | Market Commentary: Stanley Black & Decker notches strong debut; Dermira deal touted; Becton Dickinson does well
|
5/11/2017 | CV | Market Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Dermira rises; Black & Decker on tap
|
5/11/2017 | CV | Market Commentary: Morning Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Black & Decker on tap
|
5/10/2017 | CV | New Issue: Dermira prices $250 million five-year 3% convertibles, up 30%
|
5/10/2017 | CV | Market Commentary: Depomed convertible notes recover from day’s lows; Vitamin Shoppe loses ground
|
5/10/2017 | CV | Market Commentary: Morning Commentary: Depomed convertibles weaken on wider loss; Dermira, Becton deals on deck
|
5/9/2017 | CV | Market Commentary: New deals from DexCom, Kaman active post-pricing; Dermira adds to calendar; Becton on tap
|
5/9/2017 | CV | Dermira selling $250 million five-year convertible notes to yield 2.75%-3.25%, up 25%-30%
|
10/8/2014 | PP | Dermira raises $7.5 million through private placement of common stock
|
9/19/2014 | PP | Dermira to price IPO of 5.35 million shares between $14.00 and $16.00
|
8/27/2014 | PP | Dermira announces plans to price initial public offering of stock
|